Bull
$8.88
Scenario price
$12.310
+0.010 (+0.08%)At close
LifeStance Health Group, Inc. is a reimagining mental health company. The Company is focused on providing virtual and in-person outpatient mental healthcare for children, adolescents and adults experiencing a variety of mental health conditions. Its patient-focused platform combines differentiated clinical capabilities with a personalized, digitally powered patient experience designed to transform patient access and treatment. Its clinicians offer patients a comprehensive, multidisciplinary suite of mental health services, spanning psychiatric evaluations and treatment, psychological and neuropsychological testing, and individual, family and group therapy. It treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders and post-traumatic stress disorder. It employs approximately 8,300 psychiatrists, advanced practice nurses, psychologists and therapists and operates across 33 states and more than 550 centers.
LifeStance Health Group Inc (LFST) is a good buy right now, trading at $12.31 with a strong recent performance, including a 26% year-over-year revenue growth reported in Q2 2026 and an adjusted EPS of $0.11, exceeding expectations. The forward P/E ratio is 71.43, indicating growth potential, while the RSI is at 55.20, suggesting a healthy momentum. However, insider selling has surged by 53168.39%, which is a notable risk.
Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

LifeStance Health Surpasses Q2 Earnings Expectations Driven by Clinician Growth

LifeStance (LFST) Q2 2026 Earnings Call Transcript

LifeStance Health Exceeds Q2 Earnings Expectations with 26% Revenue Growth

DaVita Inc. Q2 2026 Earnings Preview

LifeStance Health Group Reports Strong Q1 Earnings
LifeStance Health Group, Inc. is a reimagining mental health company. The Company is focused on providing virtual and in-person outpatient mental healthcare for children, adolescents and adults experiencing a variety of mental health conditions. Its patient-focused platform combines differentiated clinical capabilities with a personalized, digitally powered patient experience designed to transform patient access and treatment. Its clinicians offer patients a comprehensive, multidisciplinary suite of mental health services, spanning psychiatric evaluations and treatment, psychological and neuropsychological testing, and individual, family and group therapy. It treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders and post-traumatic stress disorder. It employs approximately 8,300 psychiatrists, advanced practice nurses, psychologists and therapists and operates across 33 states and more than 550 centers. It operates in the Healthcare sector (SERVICES-HEALTH SERVICES industry).
LifeStance Health Group Inc (LFST) is a good buy right now, trading at $12.31 with a strong recent performance, including a 26% year-over-year revenue growth reported in Q2 2026 and an adjusted EPS of $0.11, exceeding expectations. The forward P/E ratio is 71.43, indicating growth potential, while the RSI is at 55.20, suggesting a healthy momentum. However, insider selling has surged by 53168.39%, which is a notable risk.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.